Tenaya Therapeutics financials at a glance

+ Portfolio

The revenue of Tenaya Therapeutics is reported as 0 billion Dollars in the fiscal year 2023. The earnings were -1.7 Dollars per share in 2023, which was 32.68 higher than 2021. And about -0.02063 billion Dollars are reported as free cash flow in the financials of Tenaya Therapeutics 2023. No dividends were paid to the shareholders of the Tenaya Therapeutics stock NasdaqGS:TNYA in the financial year 2023.

$0.00M

Revenue

$-2.76

Earnings Per Share

0.00%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

0.00

Earnings Per Share

-2.76

Gross Margin %

0.00

Free Cash Flow

0.00

Financials

Year	Year	TTM	2022	2021
Rev.	Revenue	N/A	$0.00M	$0.00M
GM %	Gross Margin %	0.00%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-1.85	$-2.76	$-4.10
Div.	Dividends	N/A	$0.00	$0.00
PR %	Payout Ratio %	0	0	0
Sha.	Shares	N/AM	66.87M	41.29M
OCF	Operating Cash Flow	N/A	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$0.00M	$0.00M
FCFS	Free Cash Flow Per Share	$-1.51	$-2.79	$-4.85

Tenaya Therapeutics financials at a glance

Financials

Discover